Pacific Edge Limited
Records under this name other than the patents Pacific Edge Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,822,149 | Prognosis Prediction for Melanoma Cancer Lapsed on the fee record Ended Sep 2, 2026 · High confidence | Lapsed on the fee record | Ended Sep 2, 2026 | High confidence |
| US 10,024,859 | Markers for Detection of Gastric Cancer Lapsed on the fee record Ended Jul 17, 2026 · High confidence | Lapsed on the fee record | Ended Jul 17, 2026 | High confidence |
| US 9,982,305 | Polymerase Chain Reaction Test Kits for Detecting Markers of Bladder Cancer Lapsed on the fee record Ended May 29, 2026 · High confidence | Lapsed on the fee record | Ended May 29, 2026 | High confidence |
| US 11,208,698 | Methods for Detection of Markers Bladder Cancer and Inflammatory Conditions of the Bladder and Treatment Thereof Lapsed on the fee record Ended Dec 28, 2025 · High confidence | Lapsed on the fee record | Ended Dec 28, 2025 | High confidence |
| US 11,180,815 | Methods for treating colorectal cancer using prognostic genetic markers Lapsed on the fee record Ended Nov 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 23, 2025 | From the USPTO record |
| US 9,809,860 | Test Kits and Methods for Their Use in Detecting Expression Ratios of Genetic Markers Lapsed on the fee record Ended Nov 7, 2025 · Medium confidence | Lapsed on the fee record | Ended Nov 7, 2025 | Medium confidence |
| US 11,130,789 | Urine markers for detection of bladder cancer Lapsed on the fee record Ended Sep 28, 2025 · High confidence | Lapsed on the fee record | Ended Sep 28, 2025 | High confidence |
| US 9,702,009 | Urine Gene Expression Ratios for Detection of Cancer Lapsed on the fee record Ended Jul 11, 2025 · Medium confidence | Lapsed on the fee record | Ended Jul 11, 2025 | Medium confidence |
| US 9,534,258 | Devices and Methods for Prognosis Prediction for Melanoma Cancer Formerly held Lapsed on the fee record Ended Jan 3, 2025 · High confidence | Lapsed on the fee record | Ended Jan 3, 2025 | High confidence |
| US 10,689,707 | Treatment of recurrent gastric cancer identified using genetic biomarkers Lapsed on the fee record Ended Jun 23, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 23, 2024 | From the USPTO record |